NCT00303446View on ClinicalTrials.gov

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

PHASE2CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Kennedy's DiseaseSpinal and Bulbar Muscular Atrophy
Interventions
DRUG

Dutasteride

Dutasteride 0.5 mg/day

DRUG

Placebo

Matched placebo

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00303446 - Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) | Biotech Hunter | Biotech Hunter